Eli Lilly & Co. (LLY) Financials Nov 18, 2014, 9:4
Post# of 250665
Posted On: 11/18/2014 9:47:44 AM
Eli Lilly & Co. (LLY) Financials Nov 18, 2014, 9:47 a.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Eli Lilly & Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 21.84B 23.08B 24.29B 22.6B 23.11B
Cost of Goods Sold (COGS) incl. D&A 4.25B 4.37B 5.07B 4.8B 4.91B
COGS excluding D&A 2.95B 3.04B 3.69B 3.33B 3.46B
Depreciation & Amortization Expense 1.3B 1.33B 1.37B 1.46B 1.45B
Depreciation 813.5M 749.1M 732.4M 754M 890.6M
Amortization of Intangibles 484.3M 579.1M 641.2M 708.2M 555M
Gross Income 17.59B 18.71B 19.22B 17.81B 18.21B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.22B 11.94B 12.9B 12.79B 12.66B
Research & Development 4.33B 4.88B 5.02B 5.28B 5.53B
Other SG&A 6.89B 7.05B 7.88B 7.51B 7.13B
Other Operating Expense 0 0 0 0 0
Unusual Expense 782.7M 221M 683M (479.9M) (291M)
EBIT after Unusual Expense (782.7M) (221M) (683M) 479.9M 291M
Non Operating Income/Expense (43.4M) 107.6M (179.3M) (14.2M) 90.6M
Non-Operating Interest Income 75.2M 51.9M 79.9M 105M 119.7M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 261.3M 185.5M 186M 177.8M 160.1M
Gross Interest Expense 291.5M 211.5M 211.7M 198.8M 184.2M
Interest Capitalized 30.2M 26M 25.7M 21M 24.1M
Pretax Income 5.36B 6.53B 5.35B 5.41B 5.89B
Income Tax 1.03B 1.46B 1B 1.32B 1.2B
Income Tax - Current Domestic 94.9M 399.5M 648.5M 653M 385.4M
Income Tax - Current Foreign 772.2M 513.9M 759.5M 540.6M 553.2M
Income Tax - Deferred Domestic 82.1M 597.5M (371.5M) 96.1M 294.1M
Income Tax - Deferred Foreign 79.8M (55.2M) (34.7M) 29.9M (28.2M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.33B 5.07B 4.35B 4.09B 4.68B
Minority Interest Expense 0 0 0 0 0
Net Income 4.33B 5.07B 4.35B 4.09B 4.68B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.33B 5.07B 4.35B 4.09B 4.68B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.33B 5.07B 4.35B 4.09B 4.68B
EPS (Basic) 3.94 4.58 3.90 3.67 4.33
Basic Shares Outstanding 1.1B 1.11B 1.11B 1.11B 1.08B
EPS (Diluted) 3.94 4.58 3.90 3.66 4.32
Diluted Shares Outstanding 1.1B 1.11B 1.11B 1.12B 1.08B
EBITDA 7.67B 8.1B 7.69B 6.48B 6.99B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Eli Lilly & Co.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 21.84B 23.08B 24.29B 22.6B 23.11B
Cost of Goods Sold (COGS) incl. D&A 4.25B 4.37B 5.07B 4.8B 4.91B
COGS excluding D&A 2.95B 3.04B 3.69B 3.33B 3.46B
Depreciation & Amortization Expense 1.3B 1.33B 1.37B 1.46B 1.45B
Depreciation 813.5M 749.1M 732.4M 754M 890.6M
Amortization of Intangibles 484.3M 579.1M 641.2M 708.2M 555M
Gross Income 17.59B 18.71B 19.22B 17.81B 18.21B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 11.22B 11.94B 12.9B 12.79B 12.66B
Research & Development 4.33B 4.88B 5.02B 5.28B 5.53B
Other SG&A 6.89B 7.05B 7.88B 7.51B 7.13B
Other Operating Expense 0 0 0 0 0
Unusual Expense 782.7M 221M 683M (479.9M) (291M)
EBIT after Unusual Expense (782.7M) (221M) (683M) 479.9M 291M
Non Operating Income/Expense (43.4M) 107.6M (179.3M) (14.2M) 90.6M
Non-Operating Interest Income 75.2M 51.9M 79.9M 105M 119.7M
Equity in Affiliates (Pretax) - - - - -
Interest Expense 261.3M 185.5M 186M 177.8M 160.1M
Gross Interest Expense 291.5M 211.5M 211.7M 198.8M 184.2M
Interest Capitalized 30.2M 26M 25.7M 21M 24.1M
Pretax Income 5.36B 6.53B 5.35B 5.41B 5.89B
Income Tax 1.03B 1.46B 1B 1.32B 1.2B
Income Tax - Current Domestic 94.9M 399.5M 648.5M 653M 385.4M
Income Tax - Current Foreign 772.2M 513.9M 759.5M 540.6M 553.2M
Income Tax - Deferred Domestic 82.1M 597.5M (371.5M) 96.1M 294.1M
Income Tax - Deferred Foreign 79.8M (55.2M) (34.7M) 29.9M (28.2M)
Income Tax Credits - - - - -
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 4.33B 5.07B 4.35B 4.09B 4.68B
Minority Interest Expense 0 0 0 0 0
Net Income 4.33B 5.07B 4.35B 4.09B 4.68B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.33B 5.07B 4.35B 4.09B 4.68B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.33B 5.07B 4.35B 4.09B 4.68B
EPS (Basic) 3.94 4.58 3.90 3.67 4.33
Basic Shares Outstanding 1.1B 1.11B 1.11B 1.11B 1.08B
EPS (Diluted) 3.94 4.58 3.90 3.66 4.32
Diluted Shares Outstanding 1.1B 1.11B 1.11B 1.12B 1.08B
EBITDA 7.67B 8.1B 7.69B 6.48B 6.99B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)